Cargando…
The utility of CRP with the use of dexamethasone and Tocilizumab in critically ill patients with COVID-19
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098225/ https://www.ncbi.nlm.nih.gov/pubmed/35569216 http://dx.doi.org/10.1016/j.jcrc.2022.154053 |
| _version_ | 1784706334982144000 |
|---|---|
| author | Zacharias, Harry Mungara, Ritwik Wilson, Andrew Peter Singer, Mervyn Arulkumaran, Nishkantha |
| author_facet | Zacharias, Harry Mungara, Ritwik Wilson, Andrew Peter Singer, Mervyn Arulkumaran, Nishkantha |
| author_sort | Zacharias, Harry |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9098225 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90982252022-05-13 The utility of CRP with the use of dexamethasone and Tocilizumab in critically ill patients with COVID-19 Zacharias, Harry Mungara, Ritwik Wilson, Andrew Peter Singer, Mervyn Arulkumaran, Nishkantha J Crit Care Article Published by Elsevier Inc. 2022-08 2022-05-12 /pmc/articles/PMC9098225/ /pubmed/35569216 http://dx.doi.org/10.1016/j.jcrc.2022.154053 Text en © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Zacharias, Harry Mungara, Ritwik Wilson, Andrew Peter Singer, Mervyn Arulkumaran, Nishkantha The utility of CRP with the use of dexamethasone and Tocilizumab in critically ill patients with COVID-19 |
| title | The utility of CRP with the use of dexamethasone and Tocilizumab in critically ill patients with COVID-19 |
| title_full | The utility of CRP with the use of dexamethasone and Tocilizumab in critically ill patients with COVID-19 |
| title_fullStr | The utility of CRP with the use of dexamethasone and Tocilizumab in critically ill patients with COVID-19 |
| title_full_unstemmed | The utility of CRP with the use of dexamethasone and Tocilizumab in critically ill patients with COVID-19 |
| title_short | The utility of CRP with the use of dexamethasone and Tocilizumab in critically ill patients with COVID-19 |
| title_sort | utility of crp with the use of dexamethasone and tocilizumab in critically ill patients with covid-19 |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098225/ https://www.ncbi.nlm.nih.gov/pubmed/35569216 http://dx.doi.org/10.1016/j.jcrc.2022.154053 |
| work_keys_str_mv | AT zachariasharry theutilityofcrpwiththeuseofdexamethasoneandtocilizumabincriticallyillpatientswithcovid19 AT mungararitwik theutilityofcrpwiththeuseofdexamethasoneandtocilizumabincriticallyillpatientswithcovid19 AT wilsonandrewpeter theutilityofcrpwiththeuseofdexamethasoneandtocilizumabincriticallyillpatientswithcovid19 AT singermervyn theutilityofcrpwiththeuseofdexamethasoneandtocilizumabincriticallyillpatientswithcovid19 AT arulkumarannishkantha theutilityofcrpwiththeuseofdexamethasoneandtocilizumabincriticallyillpatientswithcovid19 AT zachariasharry utilityofcrpwiththeuseofdexamethasoneandtocilizumabincriticallyillpatientswithcovid19 AT mungararitwik utilityofcrpwiththeuseofdexamethasoneandtocilizumabincriticallyillpatientswithcovid19 AT wilsonandrewpeter utilityofcrpwiththeuseofdexamethasoneandtocilizumabincriticallyillpatientswithcovid19 AT singermervyn utilityofcrpwiththeuseofdexamethasoneandtocilizumabincriticallyillpatientswithcovid19 AT arulkumarannishkantha utilityofcrpwiththeuseofdexamethasoneandtocilizumabincriticallyillpatientswithcovid19 |